drugset / Trial / NCT03631563

ATG-F VS ATG for the Prevention of GVHD

NCT03631563

Phase 2/3 Unknown 120 enrolled Fujian Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

Anti-thymocyte globulin (ATG) preparative regimen in the setting of haploidentical stem cell transplantation (haplo-HSCT) is vital for inducing immune tolerance.The study aims to compare the efficacy and safety of ATG-F vs ATG, incorporated into the preparative regimens for haplo-identical transplants.

Timeline

Start
2013-03-01
Primary completion
2018-12-01
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE) Protein / enzyme biologic
Subject Thymoglobulin Protein / enzyme biologic